US ENT Partners is excited to announce a new multi-year strategic partnership with Aerin Medical, the market leader in radiofrequency treatments for chronic nasal conditions.
Through this partnership, Aerin Medical has been named US ENT Partners’ preferred vendor for radiofrequency technologies. The agreement expands access to Aerin’s VivAer® and RhinAer® platforms across the US ENT network, which includes more than 1,500 physicians and 300 member practices nationwide.
Together, US ENT Partners and Aerin Medical will help broaden awareness of radiofrequency-based treatment options while giving independent ENT practices greater access to innovative, minimally invasive technologies designed for the office setting.
Expanding Treatment Options for Nasal Airway Obstruction
VivAer® is an incisionless treatment designed to address the underlying causes of nasal airway obstruction.
Using Aerin Medical’s proprietary temperature-controlled radiofrequency technology, VivAer enables physicians to treat multiple areas of the nasal airway, including the nasal valve, inferior turbinate, and septal swell body.
The procedure can be performed in-office under local anesthesia and typically involves minimal downtime for patients, giving ENT physicians another option for providing advanced nasal airway care within their practices.
A Comprehensive Approach to Chronic Rhinitis
RhinAer® provides an in-office treatment option for patients experiencing chronic rhinitis symptoms, including runny nose, post-nasal drip, congestion, itching, and sneezing.
The technology targets the posterior nasal nerve to help provide long-lasting symptom relief. Like VivAer, RhinAer uses temperature-controlled radiofrequency technology and can be performed under local anesthesia.
More than 200,000 patients have been treated with VivAer and RhinAer to date, demonstrating the growing adoption of these technologies within ENT care.
Supporting Independent ENT Practices
“When our members evaluate a technology partner, they are looking for real innovation, a serious commitment to clinical evidence, and a field team they can rely on,” said Dr. Keith Matheny, Founder, Chairman, and Chief Executive Officer of US ENT Partners. “Aerin Medical delivers on all three, and we are proud to bring the full value of the Aerin portfolio to our physician network.”
The partnership strengthens the growing portfolio of preferred vendor programs available to US ENT members. It also supports physicians as they expand the range of care they can provide within their practices while improving operational efficiency and practice performance.
“Confirmation as US ENT Partners’ preferred vendor for RF technologies is additional, meaningful validation of Aerin’s continued leadership,” said Matt Brokaw, Chief Executive Officer of Aerin Medical. “This partnership creates a clear path for US ENT members to bring VivAer and RhinAer to their patients who need lasting relief, and underscores our mutual momentum.”
Bringing More Innovative Solutions to ENT Care
At US ENT Partners, our goal is to help independent ENT practices access the technologies, resources, and preferred contracting opportunities they need to strengthen patient care and practice performance.
We are proud to welcome Aerin Medical to the US ENT Partners network and look forward to working together to expand access to innovative treatment options for chronic nasal conditions.
Learn More
Already a US ENT member?
Contact membersupport@usentpartners.com to learn more about the Aerin Medical program and preferred contracting opportunities available through US ENT Partners.
Not a member yet?
Become a US ENT Partners member to access our growing portfolio of preferred vendor partnerships, programs, and resources.